Treating liver diseases
This document provides methods and materials related to treating liver conditions. For example, the methods and materials relating to the use of cAMP inhibitors to treat liver conditions are provided.
1. A method for reducing kidney cyst volume in a mammal identified as having a kidney cyst, wherein said method comprises contacting said kidney cyst within said mammal with a formulation consisting of (a) a therapeutically effective amount of a somatostatin analog and (b) one or more pharmaceutically acceptable vehicles, lactic acid, mannitol, sodium bicarbonate, or a combination thereof, wherein the volume of said kidney cyst is reduced after said contacting step as compared to the volume of said kidney cyst before said contacting step.
2. The method of claim 1 , wherein said mammal is a human.
3. The method of claim 1 , wherein said somatostatin analog is octreotide, lanreotide, or vapreotide.